Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Niels Emil Ulrich Hermansen

10PUBLICATIONS
23CO-AUTHORS
Medical mycologyImmunogenetics (incl. genetic immunology)PharmacogenomicsUrban informaticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Mar 30, 2026
Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.

Lærke Sloth Andersen, Cecilie Velsø Mæng, Sæmundur Rögnvaldsson

|Apr 28, 2025
Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis.

Cecilie Velsoe Maeng, Sæmundur Rögnvaldsson, Thórir Einarsson Long

|Nov 29, 2023
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen

|Nov 22, 2022
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.

Lise Dueholm Bertelsen, Lars Børty Nielsen, Heidi Søgaard Christensen

|Dec 30, 2021
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen

|Oct 13, 2021
The real-world outcomes of multiple myeloma patients treated with daratumumab.

Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring

Pageof 2

Frequent Collaborators

6 joint publications

Annette Juul Vangsted

4 joint publications

Agoston Gyula Szabo

2 joint publications

Sigrún Thorsteinsdóttir

2 joint publications

Carsten Utoft Niemann

2 joint publications

Christian Brieghel

2 joint publications

Sigurður Yngvi Kristinsson

2 joint publications

Thórir Einarsson Long

2 joint publications

Cecilie Velsoe Maeng

1 joint publications

Katrine Fladeland Iversen

1 joint publications

Lise Dueholm Bertelsen

Frequent Collaborators

6 joint publications

Annette Juul Vangsted

4 joint publications

Agoston Gyula Szabo

2 joint publications

Sigrún Thorsteinsdóttir

2 joint publications

Carsten Utoft Niemann

Top Related Videos

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on : Mar 29, 2017

12.4K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

498
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.2K
See more related videos

Top Related Videos

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on : Mar 29, 2017

12.4K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

498
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.2K
See more related videos